APA (7th ed.) Citation

DY, L., SH, C., LH, L., QQ, Y., LP, T., & LO, C. (2025). Luteolin delays the progression of IgA nephropathy by attenuating inflammation, oxidative stress and reducing extracellular matrix accumulation through activating the Nrf-2/HO-1 pathway. Frontiers in pharmacology, 16, 1530655. https://doi.org/10.3389/fphar.2025.1530655

Chicago Style (17th ed.) Citation

DY, Liang, Cong SH, Li LH, Yi QQ, Tang LP, and Cao LO. "Luteolin Delays the Progression of IgA Nephropathy by Attenuating Inflammation, Oxidative Stress and Reducing Extracellular Matrix Accumulation Through Activating the Nrf-2/HO-1 Pathway." Frontiers in Pharmacology 16 (2025): 1530655. https://doi.org/10.3389/fphar.2025.1530655.

MLA (9th ed.) Citation

DY, Liang, et al. "Luteolin Delays the Progression of IgA Nephropathy by Attenuating Inflammation, Oxidative Stress and Reducing Extracellular Matrix Accumulation Through Activating the Nrf-2/HO-1 Pathway." Frontiers in Pharmacology, vol. 16, 2025, p. 1530655, https://doi.org/10.3389/fphar.2025.1530655.